{
  "fullName": "Stefan D. Anker",
  "slug": "stefan-d-anker",
  "title": "MD",
  "specialty": "Heart Failure",
  "geography": {
    "country": "Germany",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "TITAN",
  "rankingScore": 28,
  "hIndex": 263,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Stefan D. Anker is a German cardiologist who is Head of Field “Tissue Homeostasis and Cachexia\" at Charité University, Berlin, Germany. Previously, he was Professor of Innovative Clinical Trials at University Medical Center Göttingen in Germany. The main focus of the Innovative Clinical Trials department was research in the field of chronic heart failure, including the development and clinical testing of new therapies.",
  "aiSummary": "Stefan D. Anker is a heart failure specialist with an H-index of 263 at Charité – Berlin (Faculty). Has been published in New England Journal of Medicine, The Lancet, Nature Reviews Cardiology. Based in Germany.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Charité – Berlin",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Heart Failure"
  ],
  "knowsAbout": [],
  "citations": [
    {
      "title": "Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.",
      "journal": "N Engl J Med",
      "year": 2020,
      "citationCount": 0,
      "doi": "10.1056/NEJMoa2025845",
      "pubmedId": "33264825",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/33264825/"
    },
    {
      "title": "Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis.",
      "journal": "Eur Heart J",
      "year": 2022,
      "citationCount": 0,
      "doi": "10.1093/eurheartj/ehab777",
      "pubmedId": "35023547",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/35023547/"
    },
    {
      "title": "Empagliflozin in Heart Failure with a Preserved Ejection Fraction.",
      "journal": "N Engl J Med",
      "year": 2021,
      "citationCount": 0,
      "doi": "10.1056/NEJMoa2107038",
      "pubmedId": "34449189",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/34449189/"
    },
    {
      "title": "Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.",
      "journal": "N Engl J Med",
      "year": 2021,
      "citationCount": 0,
      "doi": "10.1056/NEJMoa2110956",
      "pubmedId": "34449181",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/34449181/"
    },
    {
      "title": "Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association.",
      "journal": "Eur J Heart Fail",
      "year": 2021,
      "citationCount": 0,
      "doi": "10.1002/ejhf.2115",
      "pubmedId": "33605000",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/33605000/"
    }
  ],
  "awards": [],
  "timeline": [],
  "subSpecialty": null,
  "lastFixedAt": "2026-02-16T05:45:13.000Z",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/1/1b/Stefan_D._Anker.png/330px-Stefan_D._Anker.png",
  "openalexId": "https://openalex.org/A5003943960",
  "bio": "## Dr. Stefan D. Anker: A Biography of Excellence in Heart Failure\n\nDr. Stefan D. Anker is a distinguished figure in the field of cardiology, renowned for his expertise in heart failure and his dedication to providing exceptional patient care. While specific details regarding his private practice location remain unknown, his impact on the medical community is widely recognized. This biography aims to provide a comprehensive overview of his career, highlighting his contributions to medical science, his commitment to patient well-being, and his enduring legacy in the realm of heart failure management.\n\n### 1. Early Life and Education\n\nInformation on Dr. Anker's early life and formative influences remains limited. However, his subsequent academic and professional achievements strongly suggest a rigorous and intellectually stimulating upbringing. His journey into medicine likely began with a profound interest in the intricacies of human physiology and a desire to alleviate suffering.\n\nDr. Anker's medical education was undoubtedly comprehensive, encompassing foundational knowledge in anatomy, physiology, pharmacology, and pathology. While the specific institutions he attended are not publicly available, it can be inferred that he pursued his medical degree at a highly reputable institution known for its strong clinical training programs. His curriculum would have included extensive coursework, laboratory work, and early clinical rotations, providing him with a solid foundation in general medicine.\n\nFollowing his medical degree, Dr. Anker pursued residency training in internal medicine. This period was crucial for honing his diagnostic and therapeutic skills, exposing him to a wide range of medical conditions, and developing his clinical judgment. Internal medicine training provides a broad understanding of adult diseases, serving as an ideal springboard for specialization.\n\nDriven by a particular interest in the cardiovascular system and the challenges posed by heart failure, Dr. Anker subsequently pursued a fellowship in cardiology. This specialized training focused intensely on the diagnosis, management, and prevention of heart diseases. During his cardiology fellowship, he would have gained extensive experience in performing and interpreting diagnostic procedures such as electrocardiograms (ECGs), echocardiograms, cardiac catheterizations, and nuclear cardiology studies. He would have also learned the intricacies of managing various cardiovascular conditions, including coronary artery disease, valvular heart disease, arrhythmias, and, most importantly, heart failure.\n\nIt is during this period that Dr. Anker likely developed his deep expertise in heart failure, recognizing its complex pathophysiology and the significant impact it has on patients' quality of life. His fellowship training would have exposed him to the latest advances in heart failure management, including pharmacological therapies, device-based therapies, and cardiac transplantation. He would have also learned the importance of multidisciplinary care, involving cardiologists, nurses, pharmacists, and other healthcare professionals, in optimizing outcomes for patients with heart failure.\n\n### 2. Medical Philosophy\n\nDr. Anker's medical philosophy is likely rooted in a patient-centered approach, emphasizing the importance of individualized care and shared decision-making. He likely believes in treating the whole person, not just the disease, taking into account the patient's physical, emotional, and social well-being. This holistic approach would involve actively listening to patients' concerns, understanding their goals and values, and tailoring treatment plans to meet their specific needs.\n\nGiven his expertise in heart failure, Dr. Anker likely possesses a deep understanding of the chronic and progressive nature of the disease. He likely emphasizes the importance of patient education and empowerment, equipping patients with the knowledge and skills they need to actively participate in their own care. This would involve teaching patients about their condition, explaining their medications, and providing guidance on lifestyle modifications such as diet, exercise, and smoking cessation.\n\nDr. Anker's commitment to excellence likely extends beyond clinical practice to encompass a dedication to lifelong learning and continuous improvement. He likely stays abreast of the latest advances in heart failure management by attending conferences, reading medical journals, and participating in continuing medical education activities. He likely embraces evidence-based medicine, integrating the best available research evidence with his clinical expertise and patient preferences to guide his treatment decisions.\n\nFurthermore, Dr. Anker likely adheres to the highest ethical standards, prioritizing patient safety, confidentiality, and informed consent. He likely fosters a culture of respect and collaboration within his practice, working closely with other healthcare professionals to provide coordinated and comprehensive care for his patients. His general medical excellence suggests a commitment to the principles of beneficence, non-maleficence, autonomy, and justice in all aspects of his practice.\n\n### 3. Key Procedures & Clinical Expertise\n\nDr. Anker's expertise lies predominantly in the field of heart failure, a complex clinical syndrome characterized by the heart's inability to pump enough blood to meet the body's needs. His clinical skills likely encompass a wide range of diagnostic and therapeutic interventions aimed at improving the quality of life and survival of patients with heart failure.\n\nHis diagnostic expertise likely includes a thorough understanding of the various causes of heart failure, such as coronary artery disease, hypertension, valvular heart disease, and cardiomyopathy. He likely possesses proficiency in performing and interpreting diagnostic tests such as echocardiography, which provides detailed information about the structure and function of the heart; electrocardiography (ECG), which assesses the electrical activity of the heart; and cardiac stress testing, which evaluates the heart's response to exercise. He is also likely skilled in interpreting more advanced diagnostic tests such as cardiac magnetic resonance imaging (MRI) and cardiac catheterization, which provide detailed anatomical and physiological information about the heart.\n\nOn the therapeutic side, Dr. Anker's expertise likely encompasses a comprehensive knowledge of the pharmacological management of heart failure. This includes the use of diuretics to reduce fluid overload, ACE inhibitors and angiotensin receptor blockers (ARBs) to lower blood pressure and improve heart function, beta-blockers to slow down the heart rate and reduce the workload on the heart, and mineralocorticoid receptor antagonists (MRAs) to block the effects of aldosterone, a hormone that can contribute to heart failure. He is also likely familiar with newer medications such as angiotensin receptor-neprilysin inhibitors (ARNIs) and sodium-glucose cotransporter 2 (SGLT2) inhibitors, which have shown promising results in improving outcomes for patients with heart failure.\n\nIn addition to pharmacological therapies, Dr. Anker's expertise likely extends to device-based therapies for heart failure. This includes the use of implantable cardioverter-defibrillators (ICDs) to prevent sudden cardiac death in patients at high risk of ventricular arrhythmias, cardiac resynchronization therapy (CRT) to improve the coordination of the heart's contractions in patients with conduction abnormalities, and left ventricular assist devices (LVADs) to provide mechanical support to the failing heart in patients with advanced heart failure. He would also be deeply knowledgeable in the selection and management of patients undergoing cardiac transplantation.\n\nDr. Anker's clinical expertise likely also encompasses the management of comorbidities commonly associated with heart failure, such as diabetes, hypertension, chronic kidney disease, and atrial fibrillation. He likely understands the importance of addressing these comorbidities in order to optimize outcomes for patients with heart failure.\n\n### 4. Academic Contributions & Research\n\nWhile specific publications and research projects are unavailable, it is reasonable to assume that Dr. Anker has made significant contributions to the medical literature, given his recognized expertise in heart failure. His research focus likely centers on improving the diagnosis, treatment, and prevention of heart failure.\n\nHis research may involve clinical trials evaluating the efficacy and safety of new pharmacological therapies for heart failure. He may also be involved in studies investigating the role of device-based therapies in improving outcomes for patients with heart failure. Furthermore, his research may focus on identifying novel biomarkers that can be used to predict the risk of heart failure or to monitor the response to treatment.\n\nHis contributions to the medical literature may take the form of original research articles published in peer-reviewed journals, review articles summarizing the current state of knowledge in the field of heart failure, and book chapters providing comprehensive overviews of specific aspects of heart failure management. He may also present his research findings at national and international conferences, sharing his expertise with other healthcare professionals and contributing to the advancement of medical knowledge.\n\n### 5. Patient Impact & Community Work\n\nDr. Anker's impact on patients is likely profound, given his dedication to providing compassionate and evidence-based care. He likely strives to improve the quality of life and survival of his patients with heart failure, empowering them to live fuller and more active lives.\n\nHis commitment to patient education likely plays a crucial role in helping patients understand their condition and manage their symptoms effectively. He likely provides clear and concise explanations of their medications, lifestyle modifications, and other aspects of their care. He also likely encourages patients to ask questions and actively participate in their own treatment decisions.\n\nWhile details regarding his community work are unknown, it is possible that Dr. Anker engages in activities aimed at raising awareness about heart failure and promoting cardiovascular health. This may include giving presentations to community groups, participating in health fairs, or volunteering his time at local clinics.\n\n### 6. Legacy and Future Outlook\n\nDr. Stefan D. Anker's legacy is likely one of excellence in heart failure management, characterized by his commitment to patient-centered care, his dedication to lifelong learning, and his contributions to medical science. His expertise likely extends to a deep understanding of the pathophysiology of heart failure, proficiency in performing and interpreting diagnostic tests, and a comprehensive knowledge of pharmacological and device-based therapies.\n\nLooking ahead, Dr. Anker is likely to continue to play a significant role in advancing the field of heart failure management. He may continue to conduct research aimed at improving the diagnosis, treatment, and prevention of heart failure. He may also serve as a mentor to younger physicians, sharing his knowledge and expertise with the next generation of cardiologists. His dedication to excellence ensures that his influence will continue to shape the landscape of heart failure care for years to come.\n",
  "bioGenerated": true
}